As the Trump Administration moves forward with proposed policy changes to address high drug prices, a common theme is emerging: a number of the proposals have the potential to reduce Medicare reimbursement to hospitals and...more
8/10/2018
/ Add-ons ,
Centers for Medicare & Medicaid Services (CMS) ,
Comment Period ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Federal Health Care Programs (FHCP) ,
Health Care Providers ,
Hospitals ,
MCOs ,
Medicaid ,
Medicare ,
Medicare Advantage ,
Medicare Part B ,
Medicare Part D ,
MedPAC ,
Outpatient Prospective Payment System (OPPS) ,
Pay Reductions ,
Physician Fee Schedule ,
Physicians ,
Prescription Drug Coverage ,
Prescription Drugs ,
Provider Payments ,
Request For Information ,
Section 340B ,
Trump Administration
On July 31, the Centers for Medicare and Medicaid Services (CMS) published a proposed rule outlining the proposed payment rates for 2019 under the Medicare Outpatient Prospective Payment System (OPPS), one of several payment...more
The Medicare program is once again looking to reduce payments to 340B hospitals for Part B drugs and biologicals. As part of its proposed payment regulation for hospitals under the Outpatient Prospective Payment System (OPPS)...more
8/7/2018
/ Biologics ,
Biosimilars ,
Centers for Medicare & Medicaid Services (CMS) ,
Dismissals ,
Disproportionate Share Adjustments ,
Hospitals ,
Injunctive Relief ,
Medicare ,
Medicare Part B ,
Off-Campus Departments ,
Outpatient Prospective Payment System (OPPS) ,
Pay Reductions ,
Prescription Drug Coverage ,
Provider Payments ,
Ripeness ,
Rural Health Care Providers ,
Section 340B ,
Trump Administration
The Government Accountability Office (GAO) issued a report on June 28, 2018 regarding federal oversight of compliance at 340B program contract pharmacies. The 340B drug pricing program requires drug manufacturers to sell...more
On Friday, May 11, President Donald Trump and Department of Health and Human Services (HHS) Secretary Alex Azar presented the Administration's long-awaited plan to address drug pricing. The proposed framework, entitled,...more
The Department of Health and Human Services (HHS) is soliciting comments from the public on the Administration's proposals to reduce drug prices and is targeting the 340B drug pricing program as an area of focus. ...more
On April 2, 2018, CMS issued updated guidance related to the dramatic Medicare payment reductions that went into effect this year for certain 340B hospitals. The guidance explains the planned application of the payment cuts...more
4/12/2018
/ Appeals ,
Bipartisan Agreement ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Dismissals ,
Disproportionate Share Adjustments ,
Exemptions ,
Hospitals ,
Medicare ,
Medicare Advantage ,
Medicare Part B ,
New Guidance ,
Out of Network Provider ,
Outpatient Prospective Payment System (OPPS) ,
Pay Reductions ,
Preliminary Injunctions ,
Prescription Drugs ,
Proposed Legislation ,
Reversal ,
Ripeness ,
Rural Health Care Providers ,
Section 340B ,
Statutory Authority